Sticky patch could spot breast cancer at home
NCT ID NCT07220863
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a wearable adhesive patch called Feminai 1.0 that measures skin temperature and electrical signals to create a map of each breast. The goal is to see if it can accurately detect suspicious lesions compared to mammograms and biopsies. Up to 300 women aged 25-75 will wear the patch during one study visit. The device is not meant to replace standard screening but could help doctors decide who needs further testing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Feminai 1.0 wearable adhesive patch
- What this could lead to
- If successful, this could provide a non-invasive, at-home tool to help detect breast cancer earlier, potentially reducing the need for unnecessary biopsies.
- What could go wrong
- This is an early observational study, not a treatment trial. The device is investigational and may not prove accurate enough to replace standard screening. Results may not generalize to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER AWARENESS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Solis Mammography Frisco at Stonebriar
RECRUITINGFrisco, Texas, 75034, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.